bbilly, this is a very interesting question because all of the patents have been assigned to Bioshield Technologies. Therefore, it seems that the patents belong to the business. If the business can remain viable, there still would be the possibility of future contracts. Perhaps shareholders as a class (e.g."class action lawsuits"), could appeal to the SEC to forego any action which would force the business into bankruptcy and would thereby leave present shareholders without recourse.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.